BPC-157 Binding to SH3 Domains and Activation of Src Family Kinases: In Silico Modeling and Fluorescent Fusion Protein Production
This paper proposes a molecular mechanism for BPC-157, a synthetic 15-amino-acid peptide previously studied in preclinical models for regenerative and cytoprotective effects. The authors hypothesize — based on computational structural modeling and in silico docking — that BPC-157 adopts a polyproline II (PPII) helix conformation and engages the SH3 domains of Src family kinases (c-Src, Yes, Fyn). The proposed interaction is suggested to relieve autoinhibition of these kinases, potentially activating downstream FAK-ERK and PI3K-Akt signaling pathways. To build a tool for future experimental testing, the authors engineered an mCherry-BPC157₂ fusion protein, encoded it in a baculovirus vector, and expressed it in insect (Sf9) cells. Expression was confirmed by fluorescence imaging and western blot at the expected ~31 kDa size. Importantly, this study does not include human subjects, animal experiments, or in vitro binding assays — the core mechanistic claims rest entirely on computational modeling. The fusion protein work is a proof-of-concept for a future experimental reagent. Findings should be interpreted as hypothesis-generating only.
Why this grade: All mechanistic claims derive from in silico docking and structural modeling with no human, animal, or wet-lab binding data; only a fusion protein expression system was experimentally validated in insect cells.
Abstract Body Protection Compound-157 (BPC-157) is a synthetic pentadecapeptide derived from human gastric juice with regenerative and cytoprotective effects reported across diverse tissues. Despite extensive preclinical study, the precise molecular mechanism underlying BPC-157's pleiotropic pro-repair effects remains incompletely understood. A key unresolved question is whether BPC-157 acts through extracellular receptor engagement, via intracellular interactions, or through a combination of both. Drawing on preclinical literature, structural modeling, and in silico docking, I propose that BPC-157 adopts a polyproline II helix that engages the Src homology 3 (SH3) domains of Src family kinases (SFKs; c-Src, Yes, Fyn). This interaction relieves SH3 domain-mediated autoinhibition of SFKs, resulting in focal adhesion kinase (FAK)-extracellular signal-regulated kinase (ERK) and phosphoinositide 3-kinase (PI3K)-protein kinase B (Akt) signaling cascades. To enable future experimental validation, a custom baculovirus encoding an engineered mCherry-BPC157 2 fusion protein was generated and used to transduce Spodoptera frugiperda (Sf9) cells. Expression of mCherry-BPC157 2 was validated by fluorescent imaging and confirmed by western blot at the expected molecular weight (~31 kDa). Collectively, this work proposes a novel structural and functional mechanism for BPC-157, provides in silico docking support, and introduces a molecular tool to probe the BPC-157 interactome.
Educational summary of published research — not medical advice. License: cc by. Full text is shown only where licensing permits.